SRDX still holds an equity stake in Novocell. I suspect it is around 2.5% but anywhere under 5% is the accurate answer. As I recall they took a write-off sometime after Novocell merged with Cythera (who owned a quarter of the grand-fathered in stem cell lines available for federal funding). I think the Novocell investment will bear fruit, its a matter of when.
Market Data 
Markets 
AI
